Integrated BioPharma, Inc. (INBP)
0.167
-0.01
(-7.22%)
USD |
OTCM |
Aug 24, 16:00
Integrated BioPharma Total Liabilities (Quarterly) : 7.687M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 7.687M |
| December 31, 2025 | 3.778M |
| September 30, 2025 | 5.051M |
| June 30, 2025 | 4.584M |
| March 31, 2025 | 5.273M |
| December 31, 2024 | 5.934M |
| September 30, 2024 | 6.633M |
| June 30, 2024 | 6.969M |
| March 31, 2024 | 8.031M |
| December 31, 2023 | 7.155M |
| September 30, 2023 | 7.756M |
| June 30, 2023 | 6.57M |
| March 31, 2023 | 8.139M |
| December 31, 2022 | 7.40M |
| September 30, 2022 | 7.743M |
| June 30, 2022 | 6.675M |
| March 31, 2022 | 10.72M |
| December 31, 2021 | 11.00M |
| September 30, 2021 | 9.445M |
| June 30, 2021 | 11.11M |
| March 31, 2021 | 16.38M |
| December 31, 2020 | 16.83M |
| September 30, 2020 | 17.51M |
| June 30, 2020 | 16.88M |
| March 31, 2020 | 16.50M |
| Date | Value |
|---|---|
| December 31, 2019 | 16.78M |
| September 30, 2019 | 17.42M |
| June 30, 2019 | 17.90M |
| March 31, 2019 | 20.83M |
| December 31, 2018 | 22.11M |
| September 30, 2018 | 19.53M |
| June 30, 2018 | 19.80M |
| March 31, 2018 | 20.68M |
| December 31, 2017 | 22.10M |
| September 30, 2017 | 19.48M |
| June 30, 2017 | 21.12M |
| March 31, 2017 | 21.09M |
| December 31, 2016 | 22.73M |
| September 30, 2016 | 22.32M |
| June 30, 2016 | 22.41M |
| March 31, 2016 | 23.19M |
| December 31, 2015 | 23.34M |
| September 30, 2015 | 21.14M |
| June 30, 2015 | 20.94M |
| March 31, 2015 | 21.73M |
| December 31, 2014 | 22.86M |
| September 30, 2014 | 22.90M |
| June 30, 2014 | 21.74M |
| March 31, 2014 | 20.37M |
| December 31, 2013 | 21.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Medifast, Inc. | 64.02M |
| BioForce Nanosciences Holdings, Inc. | 0.0848M |
| Skinvisible, Inc. | 10.91M |
| Nevis Brands, Inc. | 0.5354M |
| Skinhealth Systems, Inc. | 431.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.67M |
| Shareholders Equity (Quarterly) | 18.98M |
| Debt to Equity Ratio | 0.1763 |
| Current Ratio | 3.252 |
| Net Debt Paydown Yield | -4.81% |